Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Post by Rumpl3StiltSkinon Apr 29, 2022 9:19am
203 Views
Post# 34641793

The Key to Theralase ACT

The Key to Theralase ACTCorrect me, If I'm wrong. Is that it isn't a traditional drug. In how it works. Since it is Photo Activated, It should work at the cellular level, regardless of a persons(species) genetic make up. So we saw a very high % in test tube 99%. Also in rats, very high. low 90s% I think.

For NMIBC in humans it is more complicated, mainly due to how the shape of bladders differ, and that makes the dosimetry very complicated. Also, the patient population is mostly older and more frail.

My take is however long it takes TLT to get thru this Phase 2 trial and achieve FDA approval, they'll have an approved cancer drug that can be used off label, to treat other cancers, most other cancer indications will probably be less complicated that NMIBC. 

The overall CR %s of other cancer indications could/should be quite high over time. As Dr.s and Clinicians get better at applying 1433, and eventually the super compounds, to future cancer indications.
<< Previous
Bullboard Posts
Next >>